Healthcare provider profile · identity verified

Andrew Michael Bryant, MD

Family Practice · SAINT LOUIS, MO · NPI 1982044327

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	162
Levothyroxine Sodium	Levothyroxine Sodium	392	91
Lisinopril	Lisinopril	297	78
Amlodipine Besylate	Amlodipine Besylate	245	71
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	213	61
Omeprazole	Omeprazole	181	52
Losartan Potassium	Losartan Potassium	174	51
Gabapentin	Gabapentin	168	52
Escitalopram Oxalate	Escitalopram Oxalate	163	36
Pantoprazole Sodium	Pantoprazole Sodium	162	51
Albuterol Sulfate Hfa	Albuterol Sulfate	160	53
Metoprolol Succinate	Metoprolol Succinate	154	45
Rosuvastatin Calcium	Rosuvastatin Calcium	146	41
Meloxicam	Meloxicam	138	41
Sertraline Hcl	Sertraline Hcl	137	35
Tramadol Hcl	Tramadol Hcl	122	37
Metformin Hcl Er	Metformin Hcl	119	29
Trazodone Hcl	Trazodone Hcl	118	34
Metformin Hcl	Metformin Hcl	116	32
Tamsulosin Hcl	Tamsulosin Hcl	115	34
Hydrochlorothiazide	Hydrochlorothiazide	113	35
Simvastatin	Simvastatin	112	26
Tizanidine Hcl	Tizanidine Hcl	112	27
Metoprolol Tartrate	Metoprolol Tartrate	111	29
Furosemide	Furosemide	110	36
Allopurinol	Allopurinol	96	27
Alprazolam	Alprazolam	94	27
Spironolactone	Spironolactone	94	28
Duloxetine Hcl	Duloxetine Hcl	92	24
Eliquis	Apixaban	90	24
Jardiance	Empagliflozin	86	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	24
Ozempic	Semaglutide	82	13
Glipizide	Glipizide	79	22
Zolpidem Tartrate	Zolpidem Tartrate	71	16
Pravastatin Sodium	Pravastatin Sodium	69	21
Pregabalin	Pregabalin	69	14
Synthroid	Levothyroxine Sodium	68	14
Potassium Chloride	Potassium Chloride	65	18
Bupropion Xl	Bupropion Hcl	64	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	17
Atenolol	Atenolol	57	16
Diclofenac Sodium	Diclofenac Sodium	56	15
Warfarin Sodium	Warfarin Sodium	56	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	55	13
Buspirone Hcl	Buspirone Hcl	55	16
Fluoxetine Hcl	Fluoxetine Hcl	55	11
Fluticasone Propionate	Fluticasone Propionate	54	25
Carvedilol	Carvedilol	50	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	13
Montelukast Sodium	Montelukast Sodium	48	15
Prednisone	Prednisone	48	38
Hydroxyzine Hcl	Hydroxyzine Hcl	47	20
Mirtazapine	Mirtazapine	47	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	21
Finasteride	Finasteride	44	15
Ipratropium Bromide	Ipratropium Bromide	44	17
Hydralazine Hcl	Hydralazine Hcl	38	15
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Diazepam	Diazepam	35	11
Oxybutynin Chloride Er	Oxybutynin Chloride	35	11
Meclizine Hcl	Meclizine Hcl	34	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Famotidine	Famotidine	33	13
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	16
Trulicity	Dulaglutide	33	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	11
Acetaminophen-Codeine	Acetaminophen With Codeine	30	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Lorazepam	Lorazepam	30	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	28	28
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	25
Irbesartan	Irbesartan	27	suppressed
Azithromycin	Azithromycin	26	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Nystatin	Nystatin	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Prazosin Hcl	Prazosin Hcl	25	suppressed
Ciclopirox	Ciclopirox	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Naproxen	Naproxen	22	suppressed
Temazepam	Temazepam	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Mounjaro	Tirzepatide	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	19
Ramipril	Ramipril	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Cephalexin	Cephalexin	18	16
Ezetimibe	Ezetimibe	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Lurasidone Hcl	Lurasidone Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Ondansetron Odt	Ondansetron	17	11
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Topiramate	Topiramate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Torsemide	Torsemide	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error